Document Detail

Moderate exercise does not enhance the positive effect of estrogen on bone mineral density in postmenopausal women.
MedLine Citation:
PMID:  1834319     Owner:  NLM     Status:  MEDLINE    
We studied the effects of physical activity and two types of estrogen treatment in a prospective study in 78 healthy postmenopausal women. A control group and two treatment groups receiving estradiol valerate and medroxyprogesterone acetate in 1- or 3-month cycles were monitored for 1 year. Half of each group took part in an exercise program. Lumbar and femoral bone mineral density increased in both of the estrogen-treatment groups. Physical exercise with estrogen treatment did not result in further increases in bone mineral densities.
J Heikkinen; E Kurttila-Matero; E Kyllönen; J Vuori; T Takala; H K Väänänen
Related Documents :
1414479 - Endurance training associated with slightly lowered serum estradiol levels decreases mi...
16480509 - Determinants of bone mass and bone size in a large cohort of physically active young ad...
11052899 - The role of physiotherapy in the prevention and treatment of osteoporosis.
6787539 - Otosclerotic involvement of the cochlea: a histologic and audiologic study.
18758899 - Independent and combined effect of nutrition and exercise on bone mass development.
10089219 - Transient dissociation of bone metabolism induced by high performance exercise: a study...
2485609 - Metabolism of red blood cells after short-term exercise in rats.
14748949 - Effect of equilibrated hydration changes on total body water estimates by bioelectrical...
21986779 - Circulation editors' picks: most read articles in exercise physiology.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Calcified tissue international     Volume:  49 Suppl     ISSN:  0171-967X     ISO Abbreviation:  Calcif. Tissue Int.     Publication Date:  1991  
Date Detail:
Created Date:  1991-11-26     Completed Date:  1991-11-26     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7905481     Medline TA:  Calcif Tissue Int     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S83-4     Citation Subset:  IM; S    
Deaconess Institute of Oulu, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Density / drug effects*,  physiology
Estradiol / analogs & derivatives,  therapeutic use
Estradiol Congeners / therapeutic use*
Exercise / physiology*
Medroxyprogesterone / analogs & derivatives,  therapeutic use
Medroxyprogesterone Acetate
Middle Aged
Osteoporosis, Postmenopausal / prevention & control
Prospective Studies
Reg. No./Substance:
0/Estradiol Congeners; 50-28-2/Estradiol; 520-85-4/Medroxyprogesterone; 71-58-9/Medroxyprogesterone Acetate; 979-32-8/estradiol valerate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A report on the feasibility of establishing a paediatric emergency dental service at Glasgow Dental ...
Next Document:  Biochemistry and genetics of Tay-Sachs disease.